AIM IMMUNOTECH INC. (AIM) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $29.00K; Additional Paid in CapitalUSD $455.31M; Retained Earnings (Accumulated Deficit)USD $-447.60M; Stockholders' Equity Attributable to ParentUSD $7.74M.
- 2026-03-31: Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $445.93M; Retained Earnings (Accumulated Deficit)USD $-443.81M; Stockholders' Equity Attributable to ParentUSD $2.12M.
- 2025-12-31: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $431.00M; Retained Earnings (Accumulated Deficit)USD $-440.79M; Stockholders' Equity Attributable to ParentUSD $-9.78M.
- 2025-09-30: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $430.53M; Retained Earnings (Accumulated Deficit)USD $-436.61M; Stockholders' Equity Attributable to ParentUSD $-6.08M.
AIM IMMUNOTECH INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $29.00K | $455.31M | $-447.60M | $7.74M | 3 month · $199.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $8.00K | $445.93M | $-443.81M | $2.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $3.00K | $431.00M | $-440.79M | $-9.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $3.00K | $430.53M | $-436.61M | $-6.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $1.00K | $426.78M | $-433.33M | $-6.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $72.00K | $426.60M | $-430.53M | $-3.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.00K | $425.50M | $-426.83M | $-1.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-11 | (m) | (m) | (m) | $6.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $59.00K | $423.71M | $-420.86M | $2.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $57.00K | $423.21M | $-417.16M | $6.10M | 3 month · $2.50M | 3 month · $80.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $50.00K | $419.41M | $-415.32M | $4.83M | (m) | 3 month · $80.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $49.00K | $419.00M | $-409.51M | $10.23M | (m) | 12 month · $243.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $48.00K | $418.80M | $-396.93M | $22.60M | (m) | 3 month · $50.00K 9 month · $182.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $48.00K | $418.51M | $-389.12M | $30.14M | (m) | 3 month · $50.00K | $690.00K | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $48.00K | $418.46M | $-384.21M | $34.99M | (m) | 3 month · $82.00K | $692.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $48.00K | $418.27M | $-380.55M | $38.47M | (m) | 12 month · $954.00K | $696.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $48.00K | $418.09M | $-376.16M | $42.70M | (m) | 3 month · $275.00K 9 month · $792.00K | $713.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $48.00K | (m) | $-369.77M | $48.78M | (m) | 3 month · $275.00K | $713.00K | $417.79M | (m) | (m) | (m) | (m) |
| 2022-03-31 | $48.00K | (m) | $-364.92M | $53.30M | (m) | 3 month · $242.00K | $715.00K | $417.46M | (m) | (m) | (m) | (m) |
| 2021-12-31 | $48.00K | $417.22M | $-361.10M | $56.88M | (m) | 12 month · $1.57M | $715.00K | $417.22M | (m) | (m) | (m) | (m) |
| 2021-09-30 | $48.00K | (m) | $-355.25M | $62.05M | (m) | 3 month · $314.00K | $725.00K | $416.78M | (m) | $-250.00K | (m) | (m) |
| 2021-06-30 | $48.00K | (m) | $-351.43M | $65.53M | (m) | 3 month · $480.00K | $725.00K | $416.44M | (m) | $-247.00K | (m) | (m) |
| 2021-03-31 | $48.00K | $415.95M | $-345.55M | $70.97M | (m) | 3 month · $526.00K | $725.00K | (m) | (m) | $-208.00K | (m) | (m) |
| 2020-12-31 | $42.00K | $402.54M | $-341.97M | $61.29M | (m) | 12 month · $1.04M | $732.00K | $402.54M | (m) | $-47.00K | (m) | 12 month · $46.00K |
| 2020-09-30 | $41.00K | (m) | $-338.57M | $61.11M | (m) | 3 month · $250.00K | $733.00K | $398.93M | (m) | $-12.00K | (m) | (m) |
| 2020-06-30 | $34.00K | (m) | $-335.27M | $46.99M | (m) | 3 month · $150.00K | $737.00K | $381.43M | (m) | $63.00K | (m) | (m) |
| 2020-03-31 | $28.00K | (m) | $-331.92M | $35.13M | (m) | 3 month · $196.00K | (m) | $366.24M | (m) | $-4.00K | (m) | 3 month · $46.00K |
| 2019-12-31 | $10.00K | (m) | $-327.57M | $13.44M | (m) | (m) | $778.00K | $340.23M | (m) | (m) | (m) | 12 month · $2.79M |
| 2019-09-30 | $6.00K | (m) | $-326.92M | $13.44M | (m) | (m) | (m) | $339.97M | $1.00K | (m) | (m) | 9 month · $2.79M |
| 2019-06-30 | $2.00K | (m) | $-323.97M | $6.55M | (m) | (m) | (m) | $329.29M | $1.00K | (m) | (m) | 6 month · $2.79M |
| 2019-03-31 | $63.00K | (m) | $-321.94M | $3.93M | (m) | (m) | (m) | $323.29M | (m) | (m) | (m) | 3 month · $2.79M |
| 2018-12-31 | $1.00K | (m) | $-318.58M | $5.58M | (m) | (m) | (m) | $323.75M | $-3.00K | (m) | (m) | 12 month · $-221.00K |
| 2018-09-30 | $48.00K | (m) | $-316.97M | $6.44M | (m) | (m) | (m) | $323.36M | (m) | (m) | (m) | 9 month · $-221.00K |
| 2018-06-30 | $47.00K | (m) | $-313.89M | $9.10M | (m) | (m) | (m) | $322.95M | $-9.00K | (m) | (m) | 6 month · $-221.00K |
| 2018-03-31 | $39.00K | (m) | $-311.47M | $10.20M | (m) | (m) | (m) | $321.63M | $-1.00K | (m) | (m) | 3 month · $221.00K |
| 2017-12-31 | $33.00K | (m) | $-308.76M | $8.70M | (m) | (m) | (m) | $317.42M | $11.00K | (m) | (m) | 12 month · $2.05M |
| 2017-09-30 | $31.00K | (m) | $-306.77M | $10.04M | (m) | (m) | (m) | $316.75M | $29.00K | (m) | (m) | 9 month · $-2.05M |
| 2017-06-30 | $29.00K | (m) | $-306.02M | $10.33M | (m) | (m) | (m) | $316.31M | $18.00K | (m) | (m) | 6 month · $-1.99M |
| 2017-03-31 | $26.00K | (m) | $-303.32M | $12.95M | (m) | (m) | (m) | $316.24M | $6.00K | (m) | (m) | 3 month · $734.00K |
| 2016-12-31 | $24.00K | (m) | $-300.50M | $15.50M | (m) | (m) | (m) | $315.98M | $-5.00K | (m) | (m) | 12 month · $-2.62M |
| 2016-09-30 | $24.00K | (m) | $-299.33M | $16.63M | (m) | (m) | (m) | $315.86M | $71.00K | (m) | (m) | 9 month · $2.62M |
| 2016-06-30 | $249.00K | (m) | $-296.47M | $17.49M | (m) | (m) | (m) | $313.62M | $87.00K | (m) | (m) | (m) |
| 2016-03-31 | $247.00K | (m) | $-295.16M | $18.41M | (m) | (m) | (m) | $313.27M | $50.00K | (m) | (m) | (m) |
| 2015-12-31 | $21.00K | (m) | $-293.00M | $20.37M | (m) | (m) | (m) | $313.45M | $-97.00K | (m) | (m) | (m) |
| 2015-09-30 | $248.00K | (m) | $-289.86M | (m) | (m) | (m) | $0.00 | $313.19M | (m) | $-401.00K | $23.17M | (m) |
| 2015-06-30 | $245.00K | (m) | $-286.06M | (m) | (m) | (m) | $0.00 | $312.76M | (m) | $-186.00K | $26.76M | (m) |
| 2015-03-31 | $226.00K | (m) | $-281.21M | (m) | (m) | (m) | $0.00 | $308.01M | (m) | $-49.00K | $26.97M | (m) |
| 2014-12-31 | $204.00K | (m) | $-277.77M | $25.00M | (m) | (m) | $0.00 | $302.73M | $-160.00K | $-160.00K | $25.00M | (m) |
| 2014-09-30 | $194.00K | (m) | $-273.31M | (m) | (m) | (m) | $0.00 | $299.60M | (m) | $-114.00K | $26.36M | (m) |
| 2014-06-30 | $189.00K | (m) | $-269.11M | (m) | (m) | (m) | $0.00 | $298.24M | (m) | $54.00K | $29.37M | (m) |
| 2014-03-31 | $183.00K | (m) | $-264.15M | (m) | (m) | (m) | $0.00 | $296.06M | (m) | $-93.00K | $31.99M | (m) |
| 2013-12-31 | $168.00K | (m) | $-260.32M | $29.30M | (m) | (m) | $0.00 | $289.56M | (m) | $-114.00K | $29.30M | (m) |
| 2013-09-30 | $167.00K | (m) | $-257.12M | (m) | (m) | (m) | $0.00 | $289.20M | (m) | $-91.00K | $32.15M | (m) |
| 2013-06-30 | $167.00K | (m) | $-251.99M | (m) | (m) | (m) | $0.00 | $289.05M | (m) | $-1.09M | $36.14M | (m) |
| 2013-03-31 | $167.00K | (m) | $-247.71M | (m) | (m) | (m) | $0.00 | $288.93M | (m) | $-7.00K | $41.38M | (m) |
| 2012-12-31 | $166.00K | (m) | $-244.09M | $44.70M | (m) | (m) | $0.00 | $288.67M | (m) | $-43.00K | $44.70M | (m) |
| 2012-09-30 | $148.00K | (m) | $-238.63M | (m) | (m) | (m) | $0.00 | $274.67M | (m) | $428.00K | $36.61M | (m) |
| 2012-06-30 | $136.00K | (m) | $-232.05M | (m) | (m) | (m) | $0.00 | $265.18M | (m) | $266.00K | $33.53M | (m) |
| 2012-03-31 | $136.00K | (m) | $-229.05M | (m) | (m) | (m) | $0.00 | $264.99M | (m) | $52.00K | $36.13M | (m) |
| 2011-12-31 | $136.00K | (m) | $-226.74M | (m) | (m) | (m) | $0.00 | $264.96M | (m) | $-389.00K | $37.97M | (m) |
| 2011-09-30 | $135.00K | (m) | $-223.62M | (m) | (m) | (m) | $0.00 | $264.93M | (m) | $-867.00K | $40.57M | (m) |
| 2011-06-30 | $135.00K | (m) | $-220.88M | (m) | (m) | (m) | $0.00 | $264.76M | (m) | $-338.00K | $43.67M | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $45.62M | (m) |
| 2010-12-31 | $135.00K | (m) | $-217.72M | (m) | (m) | (m) | $0.00 | $264.51M | (m) | $-974.00K | $45.95M | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $58.70M | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $11.54M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |